Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study.
Matthew H KulkeHagen F KenneckeKris MuraliVijay N JoishPublished in: Cancer management and research (2021)
Patients treated with TE in a real-world setting experienced significant, clinically meaningful improvements in CS symptoms.